Quantcast

Latest Lewy body Stories

2014-08-18 16:25:16

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Lewy body Dementia-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278623/-Lewy-body-Dementia-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Lewy body Dementia-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall...

2014-07-31 12:29:21

AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J. Fox Foundation NEW YORK and VIENNA, July 31, 2014 /PRNewswire/ -- AFFiRiS AG announced today at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease. PD01A is the first therapy against the protein alpha-synuclein, a promising Parkinson's drug target, to enter clinical testing. The Michael J. Fox...

2014-05-15 23:08:54

Dr. Sandeep Grewal, a primary care physician at ACE Medical Group and author of ‘Dementia Express: Lose Your Memory in 100 Ways’ discusses types of Dementia and tips to prevent Dementia and memory loss. Rock Hill, South Carolina (PRWEB) May 15, 2014 Casey Kasem's struggle with Lewy Body Dementia (LBD) underlines the fact that Dementia can affect anyone. "Kasem, 82, is suffering from Lewy body disease," according to CNN (May 15, 2014). Nearly 3 million people in the...

2014-04-28 08:33:12

EU support boosts development of therapeutic vaccines against Parkinson's and Multiple System Atrophy. AFFiRiS leads consortium. VIENNA, April 28, 2014 /PRNewswire/ -- An international consortium of top European research teams has received significant EU funding for the development of therapeutic vaccines against Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Led by the Austrian biotech company AFFiRiS AG, the consortium will use a novel tandem strategy to advance...

2014-03-10 12:26:00

LBD, the Second Most Common Progressive Dementia after Alzheimer's ATLANTA, March 10, 2014 /PRNewswire-USNewswire/ -- Today, for Brain Awareness Week, March 10-16, 2014, the Lewy Body Dementia Association (LBDA), calls attention to critical differences in dementia-causing disorders that may have potentially life-saving implications. Lewy body dementia (LBD) is the most misdiagnosed form of dementia and, following Alzheimer's disease, is the second most common cause of progressive...

2013-05-10 11:57:50

Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published online May 10 in Human Molecular Genetics, offers a unique and exciting strategy to treat neurodegenerative diseases that feature abnormal buildup of proteins in Parkinson's disease,...

2013-04-08 12:16:35

Research presented at the Genetics Society of America's ongoing annual Drosophila Conference in Washington, D.C., suggests that mannitol, a sugar substitute, could lead to a future treatment for Parkinson's disease Researchers from Tel Aviv University describe experiments that could lead to a new approach for treating Parkinson's disease (PD) using a common sweetener, mannitol. This research is presented today at the Genetics Society of America's 54th Annual Drosophila Research Conference...

2012-11-16 11:06:17

Transmission model shows two main hallmarks of Parkinson´s disease - death of dopamine neurons and disease protein clumps Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. Now, after several years of incremental study, researchers at the Perelman School of Medicine, University of Pennsylvania have been able to piece together...

2012-10-22 22:39:08

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer's disease. Due to the similarity of the symptoms, differentiating patients with Alzheimer's from those with other types of dementia — or patients with Parkinsondisease from those with other motor...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.